Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021

Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021

Abstract Background Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide, particularly in countries with limited resources. The emergence of drug resistance in mycobacterium tuberculosis (MTB), particularly rifampicin (RIF) resistance, hindered TB control efforts....

Full description

Bibliographic Details
Main Authors: Sirak Biset, Milto Teferi, Haylemesikel Alamirew, Biniyam Birhanu, Awoke Dessie, Abebe Aschale, Anmaw Haymanot, Selamu Dejenie, Teshager Gebremedhin, Wondwossen Abebe, Gashaw Adane
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Infectious Diseases
Subjects:
Tuberculosis
Rifampicin resistance
Multi-drug resistance
Ethiopia
Online Access:https://doi.org/10.1186/s12879-024-09135-0

Internet

https://doi.org/10.1186/s12879-024-09135-0

Similar Items